Inventor
WEBB PAUL
GB29 patents
⚠️ This page may combine multiple inventors who share the name “WEBB PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
5 patentsUS5723291AMar 3, 1998
Methods for screening compounds for estrogenic activity
UNIV CALIFORNIA19 citations88
US6884577B2Apr 26, 2005
Methods for screening compounds for estrogenic activity
UNIV CALIFORNIA7 citations70
US7302347B2Nov 27, 2007
Method for creating specific, high affinity nuclear receptor pharmaceuticals
UNIV CALIFORNIA7 citations67
US6117638ASep 12, 2000
Methods to screen for transcription factor-coactivator interactions
UNIV CALIFORNIA4 citations59
US6156723ADec 5, 2000
Compositions comprising inhibitors of estrogen response
UNIV CALIFORNIA1 citations48
VERNALIS R&D LTD
5 patentsUS10413550B2Sep 17, 2019
Isoxazole compounds as inhibitors of heat shock proteins
VERNALIS R&D LTD2 citations72
US9718793B2Aug 1, 2017
Isoxazole compounds as inhibitors of heat shock proteins
VERNALIS R&D LTD3 citations72
US11234987B2Feb 1, 2022
Isoxazole compounds as inhibitors of heat shock proteins
VERNALIS R&D LTD0 citations61
US10696652B2Jun 30, 2020
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
VERNALIS R&D LTD0 citations46
US9604975B2Mar 28, 2017
Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
VERNALIS R&D LTD0 citations46
IPSEN BIOPHARM LTD
3 patentsUS10561604B2Feb 18, 2020
Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
IPSEN BIOPHARM LTD10 citations81
US9757329B2Sep 12, 2017
Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
IPSEN BIOPHARM LTD8 citations81
US11534394B2Dec 27, 2022
Pharmaceutical composition containing botulinum neurotoxin
IPSEN BIOPHARM LTD0 citations59